Health Catalyst Inc
NASDAQ:HCAT

Watchlist Manager
Health Catalyst Inc Logo
Health Catalyst Inc
NASDAQ:HCAT
Watchlist
Price: 2.47 USD 0.82% Market Closed
Market Cap: 174.7m USD

Wall Street
Price Targets

HCAT Price Targets Summary
Health Catalyst Inc

Wall Street analysts forecast HCAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCAT is 4.02 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

Lowest
Price Target
3.03 USD
23% Upside
Average
Price Target
4.02 USD
63% Upside
Highest
Price Target
5.25 USD
113% Upside
Health Catalyst Inc Competitors:
Price Targets
EQS
Equasens SA
19% Upside
OMCL
Omnicell Inc
4% Upside
4263
Susmed Inc
204% Upside
5038
eWeLL Co Ltd
15% Upside
ALC
Alcidion Group Ltd
15% Upside
SDGR
Schrodinger Inc
51% Upside
4480
Medley Inc
42% Upside
ALMDT
Median Technologies SA
110% Upside

Revenue
Forecast

Revenue Estimate
Health Catalyst Inc

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 4 years is 2%.

18%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

Net Income
Forecast

Net Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HCAT's stock price target?
Price Target
4.02 USD

According to Wall Street analysts, the average 1-year price target for HCAT is 4.02 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

What is Health Catalyst Inc's Revenue forecast?
Projected CAGR
2%

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 4 years is 2%.

Back to Top